Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Robert Davis
Pharma
Merck splits human pharma business, establishing oncology unit
Merck is reorganizing its human health business into a distinct oncology division and a separate specialty, pharma and infectious diseases unit.
Fraiser Kansteiner
Feb 23, 2026 10:25am
Merck lines up $70B+ in revenue opportunities over next decade
Feb 3, 2026 12:14pm
The 10 highest-paid Big Pharma CEOs of 2024
Jun 16, 2025 3:00am
Merck CEO talks strategy amid tariff, policy uncertainty
Apr 24, 2025 11:27am
Merck CEO Rob Davis' 2024 pay climbed 13% to $23.2M
Apr 10, 2025 11:50am
Merck halts Gardasil shipments to China, pulls $11B sales target
Feb 4, 2025 12:10pm
